The purpose of this symposium is to explore new aspects of epidemiology in rare endocrine diseases and how new methodology has changed the landscape of several rare conditions. We will also focus on how genomics is changing the way we view rare endocrine condition, both in terms of pathophysiology, but also how genomics is changing […]